A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...

British mother Lucy took to her TikTok @lucy52915 to showcase her impressive weight loss journey - and share her three top ...

There's been plenty of buzz about this class of drug, following publication of a high-profile trial this year. How much do we ...

Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs.

DehydraTECH-semaglutide reduces overall side effects by 36.5% as compared to Rybelsus®DehydraTECH-semaglutide reduces gastrointestinal side effects by 43.5% as compared to Rybelsus®DehydraTECH-GLP-1 s ...

CBL-514, Caliway's first-in-class lipolysis drug candidate, has been granted clearance from the U.S. FDA to proceed with SUPREME-01, a global, ...

FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs.  But the drugs can leave some ...

A MUM who lost a staggering nine stone on a weight-loss jab says her hair started falling out in clumps, until she found an ...

Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

Weight-loss injections like semaglutide are trending in India, but are they safe? Know the science, risks, and why expert ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...